AbCellera Biologics Inc.

ABCL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001703057

SEC filings (opens in a new tab)

In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding AbCellera Biologics Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of ABCL: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	148	1	139	−8
Shares	114.4M	3.80M	105.6M	−4.95M (−4.5%)
Value	$338.3M	$11.3M	$274.6M	−$52.5M (−16.0%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (19)

Institutions that held AbCellera Biologics Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to ABCL in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	3,988,692	$10.4M	0.00%
Walleye Capital LLC	256,881	$667.9K	0.01%
HRT Financial LP	129,904	$337.0K	0.00%
ADAR1 Capital Management, LLC	114,981	$299.0K	0.05%
DnB Asset Management AS	58,237	$151.4K	0.00%
Creative Planning	35,799	$93.1K	0.00%
Clarkston Capital Partners, LLC	22,000	$57.2K	0.00%
Ballentine Partners, LLC	20,732	$53.9K	0.00%
Cetera Investment Advisers	13,877	$36.1K	0.00%
Acadian Asset Management LLC	13,371	$34.0K	0.00%
Brevan Howard Capital Management LP	12,886	$33.5K	0.00%
Kestra Private Wealth Services, LLC	11,000	$28.6K	0.00%
Arcadia Investment Management Corp	10,000	$26.0K	0.00%
Baader Bank INC	12,000	$22.4K	0.00%
Aviso Financial Inc.	6,540	$17.0K	0.00%
Bryn Mawr Trust Co	5,968	$15.5K	0.00%
FMR LLC	750	$1.95K	0.00%
Allworth Financial LP	351	$913	0.00%
Morton Brown Family Wealth, LLC	75	$195	0.00%

Sold out (27)

Institutions that held AbCellera Biologics Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of ABCL in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Capital World Investors	5,318,793	$15.7M
Founders Fund VII Management, LLC	3,773,530	$11.2M
Exome Asset Management LLC	514,900	$1.52M
Founders Fund Growth Management, LLC	407,017	$1.20M
Ameriprise Financial Inc	289,836	$857.9K
Belmont Capital, LLC	260,000	$769.6K
Commonwealth of Pennsylvania Public School Empls Retrmt Sys	250,248	$740.7K
Tudor Investment Corp Et Al	236,649	$700.5K
Dimensional Fund Advisors LP	179,882	$532.5K
Dark Forest Capital Management LP	146,001	$432.2K
Toronto Dominion Bank	140,000	$414.4K
Prelude Capital Management, LLC	120,900	$357.9K
Macquarie Group Ltd	119,399	$353.0K
Sumitomo Mitsui Trust Holdings, Inc.	62,759	$185.8K
Nan Fung Group Holdings Ltd	50,971	$150.9K
Headlands Technologies LLC	49,393	$146.2K
Balyasny Asset Management LLC	34,794	$103.0K
XTX Topco Ltd	33,590	$99.4K
Parkwood LLC	32,357	$96.0K
Engineers Gate Manager LP	30,761	$91.1K
Dynamic Technology Lab Private Ltd	29,112	$86.0K
Virtu Financial LLC	14,604	$43.0K
Woodline Partners LP	12,163	$36.0K
Seelaus Asset Management LLC	10,000	$29.6K
Beaird Harris Wealth Management, LLC	600	$1.78K
The PNC Financial Services Group, Inc.	200	$592
Bell Investment Advisors, Inc	136	$403

Not filed for Q3 2024 yet (1)

Institutions that held AbCellera Biologics Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ABCL in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	3,803,477	$11.3M